Intracellular single-chain antibody inhibits integrin VLA-4 maturation and function

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Integrins are crucial cell surface receptors involved in cell adhesion and signaling.
• Integrin alpha 4 beta 1 plays a key role in immune cell trafficking and adhesion to VCAM-1 and fibronectin.
• Targeting integrins is a therapeutic strategy for inflammatory and autoimmune diseases.

Purpose of the Study:

• To investigate the efficacy of intracellularly expressed single-chain antibodies in modulating cell-surface integrin alpha 4 beta 1 expression and function.
• To assess the impact of reduced integrin alpha 4 beta 1 on cell adhesion to its ligands.

Main Methods:

• Construction and intracellular expression of a single-chain antibody targeting integrin alpha 4.
• Quantification of cell-surface integrin alpha 4 beta 1 expression using flow cytometry.
• Immunoprecipitation to confirm antibody-integrin complex formation and assess subunit maturation.
• Functional assays measuring cell adhesion to VCAM-1, fibronectin (FN40), and CS1, and cell spreading on FN40.

Main Results:

• Intracellular expression of the anti-integrin alpha 4 single-chain antibody significantly reduced cell-surface alpha 4 beta 1 integrin levels (80% in RD cells, 65-100% in Jurkat cells).
• Immunoprecipitation revealed the single-chain antibody complexed with alpha 4 and beta 1 subunits, with evidence of impaired maturation.
• Cell adhesion to VCAM-1, FN40, and CS1 was greatly impaired, and cell spreading on FN40 was nearly abolished.

Conclusions:

• Intracellular single-chain antibodies are effective in reducing or eliminating cell-surface integrin expression.
• This intracellular antibody approach leads to significant functional consequences, including impaired cell adhesion.
• The strategy is potentially applicable to other integrin subunits for therapeutic interventions.